2024 ASH Review: Current Updates in Hematologic Diseases
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas. Brands: Teflaro (ceftaroline fosamil) Dalvance (Dalbavancin) Avycaz (ceftazidime and avibactam)
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
Bristol Myers Squibb Hematology
Daiichi Sankyo, Inc.
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow. We rely on reason, ingenuity, perseverance, and empathy to make bold strides in oncology.
We commit to a culture of equity and belonging that fuels exceptional value for our patients and business and unlocks the power of our people. It is the sum of our diverse perspectives, experiences and skills that informs our collective capability.
Our success comes from experts in collaboration: our people, scientists, health care providers, advocates – and patients themselves. Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world.
Please visit www.daiichisankyo.us.
Daiichi Sankyo, Inc.
Johnson & Johnson
Kite, A Gilead Company
At Kite, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
We believe cell therapy has the ability to change the way cancer is treated. Our industry-leading cell therapy technology uses the power of a patient's own immune system to target and attack their cancer cells.
Kyowa Kirin, Inc.
Here at Menarini-Stemline, The goal of our dedicated team of scientists, specialists, researchers and developers is to build a leading biopharmaceutical company focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics.
Our purpose: We use the power of leading-edge science to save and improve lives around the world
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets innovative products and has a broad portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc.
Seagen is a global biotechnology company dedicated to developing revolutionary therapies with real impact.
eeds Privacy and Registration Refund Policy
eeds Accessibility Statement